Tibolone vs placebo
Venous thromboembolic events · postmenopausal women with or without vasomotor symptoms
It is very uncertain whether tibolone changes venous thromboembolic events (clinical evaluation) all doses compared with placebo (very low certainty).
1 finding from 1 review
- Short‐term and long‐term effects of tibolone in postmenopausal women 2016 · Cochrane Headline outcomes onlyOR 0.85 [0.37, 1.97]5 studies · 9176 participantsVery low